Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-20

Clinical Trial Update: Optimized Magnetic Resonance Brachytherapy (MR BT) in Cervix Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on optimized Magnetic Resonance Brachytherapy for cervix cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Health Network, Toronto | Conditions: Cervix Cancer | Phase 2 | Status: COMPLETED